Table 11
Reasons given by firm's to collaborate with
partners, Canada, 2009
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Degree of importance | ||||
---|---|---|---|---|
Low | Medium | High | Not applicable | |
percent | ||||
Access outside scientific expertise/knowledge | 6.2A | 19.5A | 70.0B | 4.3A |
Conduct research and development | 13.1A | 22.0A | 59.4B | 5.5A |
Access to biomass | 55.4B | 13.3A | 6.9A | 24.4A |
Access production/manufacturing facilities |
49.6B | 18.0A | 10.5A | 21.8A |
Access marketing/distribution channels |
42.8B | 23.5A | 16.6A | 17.0A |
Access partners intellectual property |
25.6B | 27.7B | 28.6B | 18.1A |
Access capital | 21.5B | 30.3B | 30.9B | 17.3A |
Access regulatory affairs expertise | 44.6B | 18.1A | 15.4A | 21.9A |
Other | 1.7A | 3.2A | 7.6A | 87.5A |
Note(s):
Due to rounding, components may not add to totals
Source(s):
Statistics Canada, Bioproducts production and development survey 2009.
- Date modified: